Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas

Journal of Infection

Volumn 54, Issue 3, 2007, Pages 298-306

  Martini, Maurizio ^a   Capello, Daniela ^b   Serraino, Diego ^c   Navarra, Assunta ^d   Pierconti, Francesco ^a   Cenci, Tonia ^a   Gaidano, Gianluca ^b   Larocca, Luigi Maria ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Department of Medical Sciences   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

AIDS; Epstein Barr virus, Non Hodgkin's lymphoma; Primary central nervous system lymphoma

Indexed keywords

ARTICLE; BACTERIAL GENE; CHI SQUARE TEST; CONTROLLED STUDY; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMMEDIATE EARLY GENE; IMMUNOBLASTIC LYMPHOMA; LYMPHOID TISSUE; NONHODGKIN LYMPHOMA; NUCLEIC ACID BASE SUBSTITUTION; PROMOTER REGION; STATISTICAL SIGNIFICANCE; TWO TAILED TEST;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DNA, VIRAL; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOID TISSUE; LYMPHOMA; LYMPHOMA, AIDS-RELATED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; STATISTICS; TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 33846952229     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.04.015     Document Type: Article

References (40)

1. Kieff E., and Liebowitz D. Epstein-Barr virus and its replication. In: Fields B., and Knipe D. (Eds). Fields virology. 2nd ed. (1990), Lippincott-Raven, New York 1889-1920
2. International Agency for Research on Cancer/World Health Organization. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpes virus 8. IARC monographs on the evaluation of carcinogenic risks to humans vol. 70 (1997), International Agency for Research on Cancer/World Health Organization
3. Tirelli U., Spina M., Gaidano G., Vaccher E., Franceschi S., and Carbone A. Epidemiological, biological and clinical features of HIV-related lymphoma in the era of highly active antiretroviral therapy. AIDS 14 (2000) 1675-1688
4. Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. Pathology and genetics of tumors of haematopoietic and lymphoid tissues (2001), International Agency for Research on Cancer/World Health Organizzation, IARC Press, Lyon
5. Gaidano G., and Carbone A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 90 (1995) 235-243
6. Knowles D.M. Molecular pathology of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Semin Diagn Pathol 14 (1997) 67-82
7. Gaidano G., Capello D., and Carbone A. The molecular basis of AIDS-related lymphomagenesis. Semin Oncol 27 (2000) 431-441
8. Carbone A., Gloghini A., Capello D., and Gaidano G. Genetic pathways and histogenetic models of AIDS-related lymphomas. Eur J Cancer 37 (2001) 1270-1275
9. Larocca L.M., Capello D., Rinelli A., Nori S., Antinori A., Gloghini A., et al. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92 (1998) 1011-1019
10. Gaidano G., Carbone A., and Dalla-Favera R. Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity. Am J Pathol 152 (1998) 623-630
11. Jenkins P.J., and Farrell P.J. Are particular Epstein-Barr virus strains linked to disease?. Semin Cancer Biol 7 (1996) 209-215
12. Munch M. Epstein-Barr virus strain characterization. APMIS 106 (1998) 425-433
13. Srivastava G., Wong K.Y., Chiang A.K., Lam K.Y., and Tao Q. Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state. Blood 95 (2000) 2443-2445
14. Chen H.L., Lung M.L., Chan K.H., Griffin B.E., and Ng M.H. Tissue distribution of Epstein-Barr virus genotypes. J Virol 70 (1996) 7301-7305
15. Buck M., Cross S., Krauer K., Kienzle N., and Sculley T.B. A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle. J Gen Virol 80 (1999) 441-445
16. Kieff E. Epstein-Barr virus and its replication. In: Fields B., and Knipe D. (Eds). Fields virology. 3rd ed. (1995), Lippincott-Raven Press, Philadelphia 2343-2396
17. Cohen J.I. Epstein-Barr virus infection. N Engl J Med 343 (2000) 481-492
18. Faulkner G.C., Krajewski A.S., and Crawford D.H. The ins and outs of EBV infection. Trends Microbiol 8 (2000) 185-189
19. Shimizu N., and Takada K. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence. J Virol 67 (1993) 3240-3245
20. Faggioni A., Zompetta C., Grimaldi S., Barile G., Frati L., and Lazdins J. Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science 232 (1986) 1554-1556
21. Kallin B., Luka J., and Klein G. Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells. J Virol 32 (1979) 710-716
22. Borras A.M., Strominger J.L., and Speck S.H. Characterization of ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction. J Virol 70 (1996) 3894-3901
23. Fahmi H., Cochet C., Hmama Z., Oolon P., and Joab I. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which require the MAPK kinase pathway. J Virol 74 (2000) 5810-5818
24. van Esser J.W., van der Holt B., Meijer E., Niesters H.G., Trenschel R., Thijsen S.F., et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogenic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 98 (2001) 972-978
25. Takada K., and Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol 63 (1989) 445-449
26. Liu S., Borras A.M., Liu P., Suske G., and Speck S.H. Binding of the ubiquitous cellular transcription factor Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. Virology 228 (1997) 11-18
27. Speck S.H., Chatila T., and Flemington E. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends in Microbiol 5 (1997) 399-405
28. Gutierrez M.I., Ibrahim M.M., Dale J.K., Greiner T.C., Straus S.E., and Bhatia K. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein Virus. J Natl Cancer Inst 94 (2002) 1757-1763
29. kip1. Am J Pathol 156 (2000) 1209-1215
30. Fassone L., Cingolani A., Martini M., Migliaretti G., Oreste P.L., Capello D., et al. Characterization of Epstein-Barr virus genotype in AIDS-related non Hodgkin's lymphoma. AIDS Res Hum Retrov 18 (2002) 19-26
31. Khanim F., Yao Q.Y., Niedobitek G., Sihota S., Rickinson A.B., and Young L.S. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88 (1996) 242-251
32. Armitage P., Berry G., and Matthews J.N.S. Statistical methods in medical research. 4th ed. (2002), Oxford University Press, Oxford 503-27, 112-37
33. Tong J.H.M., Lo W.K., Au F.W.L., Huang D., and To K. Re: Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. J Natl Cancer Inst 95 (2003) 1008-1009
34. Guidoboni M., Ponzoni M., Caggiari L., Lettini A.A., Vago R., De Re V., et al. Latent membrane protein 1 deletion mutants accumulate in Reed-Stenberg cells of human immunodeficiency virus-related Hodgkin's lymphoma. J Virol 79 (2005) 2643-2649
35. Berger C., Brousset P., McQuain C., and Knecht H. Deletion variants within the NF-kappaB activation domain of the LMP1 oncogene in acquired immunodeficiency syndrome-related large cell lymphomas, in prelymphomas and atypical lymphoproliferations. Leuk Lymphoma 26 (1997) 239-250
36. Trivedi P., Hu L.F., Chen F., Christensoon B., Masucci M.B., Klein G., et al. Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Cancer 30 (1994) 84-88
37. Trivedi P., Winberg G., and Klein G. Differential immunogenicity of Epstein-Barr virus (EBV) encoded growth transformation-associated antigens in a murine model system. Eur J Cancer 33 (1997) 912-917
38. Liu S., Liu P., Borras A., Chatila T., and Speck S.H. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J 16 (1997) 143-153
39. Liu S., Borras A.M., Liu G., Suske G., and Speck S.H. Binding of the ubiquitous cellular transcription factors sp1 and sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. Virology 228 (1997) 11-18
40. Martinez-Maza O., and Crabb Breen E. B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol 14 (2002) 528-532